Get started
Author

S. A. Bolshakov

Observed names: Bolshakov S.A. Bolshakov, S.A. Bolshakov, Stepan Bolshakov, Stepan Bolshakov Alexeevich, Большаков Степан Алексеевич, С. А. Большаков
Institution: Botkin Hospital
ORCID: 0000-0002-4556-6740
Observed ORCID: 0000-0002-4556-6740
OpenAlex ID: A5009695439
Gut microbiota and kidney diseases. Literature review
2024 · E. V. Shutov, S. A. Bolshakov, et al. · Nephrology and Dialysis · 2
PDF
DRESS syndrome on the background of adding meropenem to carbamazepine therapy: a clinical case
2022 · Yu. V. Ilina, T. A. Fedorova, et al. · Sechenov Medical Journal · 2
PDF
The gut microbiome and nonalcoholic fatty liver disease: prospects for drug therapy
2024 · D. A. Teplyuk, O. N. Levina, et al. · Экспериментальная и клиническая гастроэнтерология · 1
Secondary hyperparathyroidism. Specific features, complexity, features of treatment. Literature review. Part II - Surgical treatment
2024 · D.D. Dolidze, A.V. Shabunin, et al. · Nephrology and Dialysis · 1
PDF
#4747 the Application of Modern Medical Information Systems With Artificial Intelligence Elements for Personalized Treatment of Patients on Hemodialysis
2023 · Evgeny Shutov, Stepan Bolshakov, et al. · Nephrology Dialysis Transplantation · 1
PDF
Secondary hyperparathyroidism. Specific features, complexity, features of treatment. Literature review. Part I
2023 · A.V. Shabunin, E.V. Shutov, et al. · Nephrology and Dialysis · 1
Evaluation of humoral response to Gam-Covid-Vac (Sputnik V) vaccination against COVID-19 in patients on hemodialysis and peritoneal dialysis
2022 · Shutov E.V. Shutov, Bolshakov S.A. Bolshakov, et al. · Kliničeskaâ nefrologiâ · 1
Finerenone as a Nephroprotective Agent in IgAN: A Prospective Six-Month Pilot Study
2026 · Evgeny Shutov, Anastasiia Zykova, et al. · Journal of the American Society of Nephrology
A New Approach to Treating Patients Receiving Hemodialysis with Inflammatory Syndrome
2026 · Evgeny Shutov, Stepan Bolshakov, et al. · Journal of the American Society of Nephrology
Gut microbiota in patients undergoing hemodialysis and the effect of synbiotic therapy on its composition
2026 · E. V. Shutov, S. A. Bolshakov, et al. · Nephrology and Dialysis
PDF
Wcn26-4589 Comparison Serum Metabolic Profiles in Patients on Peritoneal Dialysis and Hemodialysis
2026 · Evgeny Shutov, Stepan Bolshakov, et al. · Kidney International Reports
#2026 The effects of interventions synbiotics on serum metabolic profiles in hemodialysis patients.
2025 · Evgeny Shutov, Stepan Bolshakov, et al. · Nephrology Dialysis Transplantation
Wcn25-1344 Gut Microbiota and Blood Metabolic Profile in Patients on Peritoneal Dialysis
2025 · Evgeny Shutov, Stepan Bolshakov, et al. · Kidney International Reports
PDF
Gut Microbiota in Patients on Peritoneal Dialysis
2024 · Shutov Evgeny, Stepan Bolshakov Alexeevich, et al. · Journal of the American Society of Nephrology
#1585 Ten years’ practice with calcimimetics and paricalcitol for the treatment of secondary hyperparathyroidism. Experience of one dialysis center
2024 · Evgeny Shutov, Galina Kotlyarova, et al. · Nephrology Dialysis Transplantation
PDF
Wcn24-2328 the Use of Monoclonal Antibodies (tixagevimab and Ciglavimab) for Preexposure Prophylaxis of Severe Covid-19 Infection in Patients on Hemodialysis
2024 · Evgeny Shutov, Stepan Bolshakov, et al. · Kidney International Reports
Микробиота кишечника и метаболом у больных, получающих перитонеальный диализ
2024 · Е. В. Шутов, С. А. Большаков, et al. · Effective Pharmacotherapy
PDF
The use of modern MIS with elements of artificial intelligence in nephrology and precision renal replacement therapy
2023 · Bolshakov S.A. Bolshakov, Shutov E.V. Shutov, et al. · Kliničeskaâ nefrologiâ
#4774 the Use of Regdanvimab for the Prevention of Severe Covid-19 in Patients on Hemodialysis
2023 · Evgeny Shutov, Stepan Bolshakov, et al. · Nephrology Dialysis Transplantation
PDF
Коррекция гиперфосфатемии и не только: комплекс β-железа (III) оксигидроксида, сахарозы и крахмала в лечении минерально-костных нарушений у пациентов с терминальной стадией хронической болезни почек
· А. С. Зыкова, Е. В. Шутов, et al. · CyberLeninK (CyberLeninka)
Опыт применения ингибиторов натрий-глюкозного котранспортера 2-го типа у пациентов с хронической болезнью почек в реальной поликлинической практике Московского многопрофильного научно-клинического центра им. С.П. Боткина
· Е. В. Шутов, А. С. Зыкова, et al. · CyberLeninK (CyberLeninka)
Микробиом кишечника и неалкогольная жировая болезнь печени: перспективы лекарственной терапии
· Теплюк Дарья Андреевна, Левина Оксана Николаевна, et al. · CyberLeninK (CyberLeninka)
Works count: 22
Citation count: 9
H-index: 2
I10-index:
Year
Topic
Type